<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <contributors>
    <authors>
      <author>García-Sanz, R.</author>
      <author>Oriol, A.</author>
      <author>Moreno, M.J.</author>
      <author>Rubia, De La</author>
      <author>Payer, A.R.</author>
      <author>Hernández, M.T.</author>
      <author>Palomera, L.</author>
      <author>Teruel, A.I.</author>
      <author>Blanchard, M.J.</author>
      <author>Gironella, M.</author>
      <author>Ribas, P.</author>
      <author>Bargay, J.</author>
      <author>Abellá, E.</author>
      <author>Granell, M.</author>
      <author>Ocio, E.M.</author>
      <author>Ribera, J.M.</author>
      <author>San Miguel, J.F.</author>
      <author>Mateos, M.V.</author>
    </authors>
  </contributors>
  <titles>
    <title>Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: Results of the randomized AZABACHE Spanish trial</title>
    <secondary-title>Haematologica</secondary-title>
  </titles>
  <doi>10.3324/haematol.2015.128439</doi>
  <pages/>
  <volume/>
  <number/>
  <dates>
    <year>2015</year>
    <pub-dates>
      <date>2015</date>
    </pub-dates>
  </dates>
  <abstract/>
</record>

</records>
</xml>